drug

avalglucosidase alfa-ngpt

1 story · latest Jul 7, 2026

Status: FDA approved Aug 2021 · BLA761194
Brand: Nexviazyme

Relationships

Developed by Sanofi

Timeline

Sanofi's Nexviazyme meets all endpoints in infantile Pompe disease trial

Jul 7Clinical readoutavalglucosidase alfa-ngpt Sanofi

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.